Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2207133/will-vertex-vrtx-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2207133
Jan 08, 2024 - Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
PBYI vs. VRTX: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2207091/pbyi-vs-vrtx-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2207091
Jan 08, 2024 - PBYI vs. VRTX: Which Stock Is the Better Value Option?
0
The Best Stocks to Invest $1,000 in Right Now
https://www.fool.com/investing/2024/01/04/the-best-stocks-to-invest-1000-in-right-now/?source=iedfolrf0000001
Jan 04, 2024 - It's not too late to get in on these market beaters.
0
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024
https://www.fool.com/investing/2023/12/31/1-cathie-wood-stock-worth-buying-hand-over-fist-in/?source=iedfolrf0000001
Dec 31, 2023 - Ark Invest holds a hefty position in this gene-editing stock. Risk-tolerant investors may want to take a page from the fund's playbook on this name.
0
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
https://www.fool.com/investing/2023/12/23/1-green-flag-and-1-red-flag-for-bluebird-bio-stock/?source=iedfolrf0000001
Dec 23, 2023 - The stock has been in the news lately.
0
Could Sarepta Therapeutics Be the Next Vertex Pharmaceuticals Stock?
https://www.fool.com/investing/2023/12/22/could-sarepta-therapeutics-be-the-next-vertex/?source=iedfolrf0000001
Dec 22, 2023 - Both develop medicines for rare diseases, and each aims to conquer a niche market.
0
Top Analyst Reports for Alphabet, Comcast & NextEra Energy
https://www.zacks.com/commentary/2201007/top-analyst-reports-for-alphabet-comcast-nextera-energy?cid=CS-ZC-FT-research_daily-2201007
Dec 21, 2023 - Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Comcast Corp. (CMCSA) and NextEra Energy, Inc. (NEE).
0
Vertex (VRTX), CRISPR Get Positive CHMP Opinion for Gene-Therapy
https://www.zacks.com/stock/news/2199442/vertex-vrtx-crispr-get-positive-chmp-opinion-for-gene-therapy?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2199442
Dec 18, 2023 - Vertex (VRTX) and CRISPR get a positive CHMP opinion, recommending the conditional approval of Casgevy for the treatment of SCD and TDT.
0
5 Big Drug Stocks That May Continue to Outperform in 2024
https://www.zacks.com/stock/news/2199316/5-big-drug-stocks-that-may-continue-to-outperform-in-2024?cid=CS-ZC-FT-analyst_blog|investment_ideas-2199316
Dec 18, 2023 - Novo Nordisk (NVO), Eli Lilly (LLY), Vertex Pharmaceuticals (VRTX), Regeneron (REGN) and GSK (GSK) have been performing well this year. These stocks are poised to keep the momentum alive in 2024.
0
Biotech Stock Roundup: BLUE, CRSP & VRTX Get Gene Therapy Nod, ACAD Up on Patent News
https://www.zacks.com/stock/news/2198026/biotech-stock-roundup-blue-crsp-vrtx-get-gene-therapy-nod-acad-up-on-patent-news?cid=CS-ZC-FT-analyst_blog|stock_roundup-2198026
Dec 14, 2023 - bluebird (BLUE) and Vertex (VRTX) are in the spotlight this week on approval of therapies and pipeline news.
0